Search results
Symptoms of arthritis in children: Watch out for fever, rashes, swelling, joint stiffness
CNBC Awaaz· 6 days agoAlthough it's commonly believed that arthritis only affects adults, children can also be affected by...
Prelude and MSD partner to trial PRT3789 and Keytruda combination
Clinical Trials Arena· 6 days agoPreclinical models have shown that combining a SMARCA2 degrader with an anti-PD-1 monoclonal ...
Woman Who Received first-ever Combined Heart Pump And Pig Kidney Transplant Dies
Times Now· 6 days agoA 54-year-old grandmother - the first person to receive a mechanical heart pump along with a...
From FLiRT to FLuQE: what to know about the latest COVID variants on the rise - ET HealthWorld
The Economic Times· 6 days agoAlong with the usual viral suspects, such as influenza, RSV, and rhinoviruses (which cause the...
iTeos and GSK hit enrolment milestone with Phase III TIGIT lung cancer trial
Pharmaceutical Technology· 7 days agoiTeos will secure $35m from GlaxoSmithKline (GSK) because it has reached its development-based...
iTeos and GSK hit enrolment milestone with Phase III TIGIT lung cancer trial
Clinical Trials Arena· 7 days agoiTeos will secure $35m from GlaxoSmithKline (GSK) because it has reached its development-based...
SciRhom pulls in $70M for a new type of immune disease drug
BioPharma Dive· 7 days agoThe fundraise announced Tuesday will support development of antibody drugs SciRhom aims to evaluate...
Pharmaceutical Lyophilization Manufacturers, Companies and Solutions
Pharmaceutical Technology· 7 days agoPharmaceutical Lyophilization Manufacturers, Companies and Solutions: Introduction The lyophilization process in the pharmaceutical industry, commonly known as freeze-drying, is a critical method ...
SciRhom secures $70m for autoimmune diseases treatments
Pharmaceutical Technology· 7 days agoThe investment will expedite the development of SciRhom's therapeutic strategy, which focuses on...
Spur Therapeutics to begin Phase III gene therapy trial in Gaucher disease
Clinical Trials Arena· 7 days agoSpur Therapeutics has announced that its gene therapy candidate for Gaucher disease will soon be...